Literature DB >> 3366867

Fifteen-year experience with bloodstream isolates of coagulase-negative staphylococci in neonatal intensive care.

D G Sidebottom1, J Freeman, R Platt, M F Epstein, D A Goldmann.   

Abstract

Investigators worldwide, as well as the neonatologists and infection control team at our hospital, have reported that the incidence of coagulase-negative staphylococcal bacteremia in critically ill neonates has increased dramatically in recent years. To investigate these claims, we examined the results of all blood cultures obtained from 1970 to 1984 in our neonatal intensive care unit. Throughout this study period, coagulase-negative staphylococci were prominent blood culture isolates (crude overall incidence of 4.4 positive bacteremia workups per 100 neonates admitted; range, 2.5 to 6.7), representing 26.3 to 69.6% of all positive cultures. There was no significant increase in incidence over time by analysis of linear trend. Detailed analysis of data from 1976 and 1982 (two selected years for which complete information concerning culturing practices and patient characteristics was available) revealed that these observations were not explained by changes in the frequency of blood culturing. In both 1976 and 1982, the probability that a blood culture would grow coagulase-negative staphylococci increased steadily from 2 to 3% shortly after admission to reach a level of about 12% in week 3 of hospitalization, before declining to an intermediate level thereafter. This pattern is more consistent with nosocomial bacteremia than with contamination of blood cultures. Contrary to clinical reports, coagulase-negative staphylococci have been the principal pathogens isolated from blood cultures in our neonatal intensive care unit since at least 1970, with no measurable increase over the subsequent 14 years.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366867      PMCID: PMC266424          DOI: 10.1128/jcm.26.4.713-718.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Coagulase-negative staphylococcal septicemia: experience in a newborn intensive care unit.

Authors:  D P Munson; T R Thompson; D E Johnson; F S Rhame; N VanDrunen; P Ferrieri
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

2.  Day-specific incidence of nosocomial infection estimated from a prevalence survey.

Authors:  J Freeman; J E McGowan
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

3.  Coagulase-negative staphylococcal bacteremia in newborns.

Authors:  G Calnen; P Campognone; G Peter
Journal:  Clin Pediatr (Phila)       Date:  1984-10       Impact factor: 1.168

4.  Bacterial colonization of neonates admitted to an intensive care environment.

Authors:  D A Goldmann; J Leclair; A Macone
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

5.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations.

Authors:  M P Weinstein; L B Reller; J R Murphy; K A Lichtenstein
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

6.  Newborn intensive care and neonatal mortality in low-birth-weight infants: a population study.

Authors:  N Paneth; J L Kiely; S Wallenstein; M Marcus; J Pakter; M Susser
Journal:  N Engl J Med       Date:  1982-07-15       Impact factor: 91.245

7.  Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis.

Authors:  A Fleer; R C Senders; M R Visser; R P Bijlmer; L J Gerards; C A Kraaijeveld; J Verhoef
Journal:  Pediatr Infect Dis       Date:  1983 Nov-Dec

8.  Sepsis with coagulase-negative staphylococci in critically ill newborns.

Authors:  S Baumgart; S E Hall; J M Campos; R A Polin
Journal:  Am J Dis Child       Date:  1983-05

9.  Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic?

Authors:  J Freeman; R Platt; D G Sidebottom; J M Leclair; M F Epstein; D A Goldmann
Journal:  JAMA       Date:  1987-11-13       Impact factor: 56.272

10.  Staphylococcus epidermidis bacteremia in neonates: further observations and the occurrence of focal infection.

Authors:  G J Noel; P J Edelson
Journal:  Pediatrics       Date:  1984-11       Impact factor: 7.124

View more
  9 in total

1.  Frequency of low-level bacteremia in children from birth to fifteen years of age.

Authors:  J A Kellogg; J P Manzella; D A Bankert
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Bacteraemia in man and animals: an overview.

Authors:  J Vaid
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

3.  Isolation of Staphylococcus caprae from blood cultures of a neonate with congenital heart disease.

Authors:  B Spellerberg; K Steidel; R Lütticken; G Haase
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

4.  Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures.

Authors:  K T Kleeman; T L Bannerman; W E Kloos
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.

Authors:  M C Ramos; M Ing; E Kim; M D Witt; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

6.  Clinical significance of Staphylococcus warneri bacteremia.

Authors:  U Kamath; C Singer; H D Isenberg
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

Review 7.  Update on clinical significance of coagulase-negative staphylococci.

Authors:  W E Kloos; T L Bannerman
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

8.  Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.

Authors:  A S Bayer; C Li; M Ing
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

9.  Impact of the high-affinity proline permease gene (putP) on the virulence of Staphylococcus aureus in experimental endocarditis.

Authors:  A S Bayer; S N Coulter; C K Stover; W R Schwan
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.